|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 9/0051 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/5026 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 9/5047 | (2013.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61P 27/02 | (2018.01) |
| (11) | Number of the document | 3791883 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20191599.8 |
| Date of filing the European patent application | 2015-07-30 | |
| (97) | Date of publication of the European application | 2021-03-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462030778 P | 2014-07-30 | US |
| (72) |
ELIOTT, Dean , US
STRYJEWSKI, Tomasz P. , US
|
| (73) |
Massachusetts Eye & Ear Infirmary ,
243 Charles Street, Boston, MA 02114,
US
|
| (54) | METHOTREXATE FOR PROLIFERATIVE VITREORETINOPATHY |
| METHOTREXATE FOR PROLIFERATIVE VITREORETINOPATHY |